Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MD, PhD, Johns Hopkins University
… → 2006
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Prot #NU 24U08: ENLIGHTEN: Detection by POSLUMA Following Negative Other PET-PSMA Imaging
Ross, A. E. (PD/PI)
Blue Earth Diagnostics Limited
1/14/25 → 1/14/28
Project: Research project
-
Artificial Intelligence to Augment MRI-Based Identification of Extraprostatic Extension and Predictive Models for Prostate Cancer
Patel, H. D. (PD/PI), Bagci, U. (Other), Jawahar, A. (Other), Meeks, J. J. (Other), Miller, F. H. (Other), Murphy, A. B. (Other) & Ross, A. E. (Other)
11/20/24 → 11/19/27
Project: Research project
-
A Phase 2 Randomized Trial of Neoadjuvant Enoblituzumab versus Standard of Care in Men with High-Risk Localized Prostate Cancer: The Help Elucidate & Attack Longitudinally (HEAT) Prostate Cancer Randomized Study
Ross, A. E. (PD/PI) & Yang, X. J. (Co-Investigator)
Johns Hopkins University, Macrogenics, Inc.
4/1/24 → 7/4/28
Project: Research project
-
Optimizing treatment and advanced multi-imaging response evaluation for very high risk prostate cancer (OPTIMAL)
Sachdev, S. (PD/PI), Ross, A. E. (Co-PD/PI), Bagci, U. (Co-Investigator), Savas, H. (Co-Investigator) & Velichko, Y. (Co-Investigator)
1/31/24 → 1/31/28
Project: Research project
-
Prot #21492: A Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Study of Darolutamide Plus Androgen Deprivation Therapy (ADT) Compared with Placebo Plus ADT in Patients with High‐Risk Biochemical Recurrence (BCR) of Prostate Cancer
Ross, A. E. (PD/PI)
Fortrea, Inc., Bayer HealthCare Pharmaceuticals, Inc.
8/4/23 → 3/31/29
Project: Research project
-
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer
Shore, N. D., Antonarakis, E. S., Ross, A. E., Marshall, C. H., Stratton, K. L., Ayanambakkam, A., Cookson, M. S., McKay, R. R., Bryce, A. H. & Kaymakcalan, M. D., Jun 2025, In: Prostate Cancer and Prostatic Diseases. 28, 2, p. 250-259 10 p.Research output: Contribution to journal › Review article › peer-review
-
An Artificial Intelligence-Digital Pathology Algorithm Predicts Survival After Radical Prostatectomy From the Prostate, Lung, Colorectal, and Ovarian Cancer Trial
Li, E. V., Ren, Y., Griffin, J., Han, C., Yamashita, R., Mitani, A., Zhou, R., Huang, H. C., Yang, X., Feng, F. Y., Esteva, A., Patel, H. D., Schaeffer, E. M., Cooper, L. A. D. & Ross, A. E., May 1 2025, In: Journal of Urology. 213, 5, p. 600-607 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A Probabilistic Hadamard U-Net for MRI Bias Field Correction
Zhu, X., Pan, H., Gundogdu, B., Jha, D., Velichko, Y., Murphy, A. B., Ross, A., Turkbey, B., Cetin, A. E. & Bagci, U., 2025, Machine Learning in Medical Imaging - 15th International Workshop, MLMI 2024, Held in Conjunction with MICCAI 2024, Proceedings. Xu, X., Cui, Z., Sun, K., Rekik, I. & Ouyang, X. (eds.). Springer Science and Business Media Deutschland GmbH, p. 208-217 10 p. (Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics); vol. 15241 LNCS).Research output: Chapter in Book/Report/Conference proceeding › Conference contribution
1 Scopus citations -
Characteristic Findings in Aborted Robot-Assisted Radical Prostatectomies
Fink, K. E., Drysch, A., Handa, N., Huang, M., Kumar, S., Li, Y., Suk-Ouichai, C., Perry, K. T., Alam, R., Patel, H. D., Jawahar, A. & Ross, A. E., 2025, (Accepted/In press) In: Journal of Endourology.Research output: Contribution to journal › Article › peer-review
-
Clinical Factors Associated with Suspicious 18F-DCFPyL Prostate-Specific Membrane Antigen Positron Emission Tomography Activity in Patients Initially Managed with Radical Prostatectomy Including Prostate-Specific Antigen < 0.5 ng/mL
Li, E. V., Bennett, R., Ho, A., Wong, C., Mahenthiran, A. K., Kumar, S. K. S. R., Sun, Z., Savas, H., Rowe, S. P., Schaeffer, E. M., Patel, H. D. & Ross, A., Feb 1 2025, In: Journal of Urology. 213, 2, p. 183-191 9 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations